Alpha 2.0
Login Register
» Authors » Dominique Stephan

Dominique Stephan

Explore the profile of Dominique Stephan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 436
Followers 0
Related Specialties
Cardiology & Vascular Diseases
General Surgery
General Medicine
Top 10 Co-Authors
Sebastien Gaertner
Corina Mirea
Elena-Mihaela Cordeanu
Amer Hamade
Anne-Sophie Frantz
Jonathan Tousch
Lucas Jambert
Patrick Ohlmann
Mihaela Cordeanu
Naouel Bensalah
Published In
Int J Cardiol
Presse Med
J Clin Med
Arch Cardiovasc Dis
Res Pract Thromb Haemost
Affiliations
Soon will be listed here.
Recent Articles
1.
Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial
Couturaud F, Schmidt J, Sanchez O, Ballerie A, Sevestre M, Meneveau N, et al.
Lancet . 2025 Mar; 405(10480):725-735. PMID: 40023651
Background: In patients with venous thromboembolism at high risk of recurrence for whom extended treatment with direct oral anticoagulants has been indicated, the optimal dose is unknown. We aimed to...
2.
Home blood pressure measurement self-reporting in real-life practices using the Hy-Result app: self-monitoring and digital pathway
Postel-Vinay N, Gebara N, Asmar R, Stephan D, Lorthioir A, Amar L
Mhealth . 2024 May; 10:13. PMID: 38689612
Background: Little real-life information is available on the clinical characteristics of information and communication technologies (ICTs) users, particularly in the context of hypertension and home blood pressure measurement (HBPM). This...
3.
Inhibition of thrombin-activatable fibrinolysis inhibitor via DS-1040 to accelerate clot lysis in patients with acute pulmonary embolism: a randomized phase 1b study
Vanassche T, Rosovsky R, Moustafa F, Buller H, Segers A, Patel I, et al.
J Thromb Haemost . 2023 May; 21(10):2929-2940. PMID: 37178771
Background: The optimal treatment of intermediate-risk pulmonary embolism (PE) in hemodynamically stable patients remains unknown. Fibrinolytics reduce the risk of hemodynamic deterioration but increase bleeding risk. DS-1040, an inhibitor of...
4.
Primary Non-Aortic Lesions Are Not Rare in Marfan Syndrome and Are Associated with Aortic Dissection Independently of Age
Senemaud J, Gaudry M, Jouve E, Blanchard A, Milleron O, Dulac Y, et al.
J Clin Med . 2023 Apr; 12(8). PMID: 37109238
Purpose: The study sought to estimate the prevalence of primary non-aortic lesions (PNAL) unrelated to extension of aortic dissection (AD) in a cohort of patients with Marfan syndrome (MFS). Methods:...
5.
Management of arterial hypertension: home blood pressure measurement is a cornerstone for telemonitoring and self-management
Postel-Vinay N, Bobrie G, Asmar R, Stephan D, Amar L
Mhealth . 2023 Apr; 9:18. PMID: 37089266
The development of mobile telephones has made it possible to design blood pressure (BP) monitors with data transmission via cellular lines, contributing to the emergence of "e-health". Today, the direct-to-consumer...
6.
A Real-World Cost-Effectiveness Analysis of Rivaroxaban versus Vitamin K Antagonists for the Treatment of Symptomatic Venous Thromboembolism: Lessons from the REMOTEV Registry
Kepka S, Cordeanu E, Zarca K, Frantz A, Ohlmann P, Andres E, et al.
Medicina (Kaunas) . 2023 Jan; 59(1). PMID: 36676804
: Venous thromboembolism (VTE) represents a health and economic burden with consequent healthcare resource utilization. Direct oral anticoagulants (DOACs) have emerged as the mainstay option for VTE treatment but few...
7.
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin
Bistervels I, Bavalia R, Beyer-Westendorf J, Ten Cate-Hoek A, Schellong S, Kovacs M, et al.
Res Pract Thromb Haemost . 2022 Aug; 6(5):e12748. PMID: 35992565
Background: Postthrombotic syndrome (PTS) is a long-term complication after deep vein thrombosis (DVT) and can affect quality of life (QoL). Pathogenesis is not fully understood but inadequate anticoagulant therapy with...
8.
The Conundrum of Occult Cancer Screening in Venous Thromboembolism: Lessons from the REMOTEV Registry
Cordeanu E, Jambert L, Tousch J, Mirea C, Delatte A, Younes W, et al.
Medicina (Kaunas) . 2022 Jul; 58(7). PMID: 35888632
(1) Background and Objectives: Venous thromboembolism (VTE) is strongly associated with cancer, and may be the first event revealing occult neoplasia. Nonetheless, the reasonable extent of the etiological assessment after...
9.
SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk
Laurent S, Chatellier G, Azizi M, Calvet D, Choukroun G, Danchin N, et al.
Hypertension . 2021 Aug; 78(4):983-995. PMID: 34455813
[Figure: see text].
10.
Withdrawal Notice: Is There a Link between Lung Parenchyma Lesions, BMI, CRP and D-dimer in COVID-19 Patients Who Had Acute Pulmonary Embolism?
Hamade A, Jambert L, Tousch J, Feuerstein P, Hammas K, Degoul S, et al.
Cardiovasc Hematol Disord Drug Targets . 2021 Aug; PMID: 34387171
Bentham Science Disclaimer: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any...